Jonas, S. and Rafetseder, O. and Wild, C. (2003): [Colorectal cancer screening in Austria: Integrating coloscopy/sigmoidoscopy into the preventive medical check up. An unsystematic review]. ITA-Projektbericht 25.

Wild, C. (2003): [Cardiac resynchronisation therapy (CRT) for heart failure]. HTA-Newsletter 23: pp. 3-4.

Wild, C. (2003): [Electric stimulation for faecal incontinence]. HTA-Newsletter 23: pp. 2-3.

Antes, G. (2003): [Funding for clinical research: A programme of the German Research Foundation (DFG). Editorial]. HTA-Newsletter 23: p. 1.

Wild, C. (2003): [Cryosurgery for prostate cancer]. HTA-Newsletter 23: p. 2.

Wild, C. (2003): [Psychotherapy]. HTA-Newsletter 23: p. 4.

Wild, C. (2003): [HTA and the commercialisation of new technologies] . ITA-Newsletter December 2003: pp. 10-11.

Wild, C. (2003): [Guidance for manufacturers and medical associations on submission of evidence]. ITA-Newsletter December 2003: p. 9.

Wild, C. (2003): [HTA interactive link collection. Editorial]. HTA-Newsletter 22: p. 1.

Wild, C. (2003): [HTA and its impact in Austria]. In: Meggeneder, O. Unter-, Über- und Fehlversorgung. Vermeidung und Management von Fehlern im Gesundheitswesen: Frankfurt/Main: Mabuse-Verlag, pp. 131-146. ISBN 3-935964-31-5.

Wild, C. and Puig, S. (2003): [Non-ionic contrast media: clinical relevance of different CM-products]. ITA-Projektbericht 24.

Wild, C. and Jonas, S. and Schamberger, C. (2003): Predictive genetic testing for hereditary cancer. Value in Health 6 (6): pp. 794-795.

Wild, C. (2003): [Hip arthroplasty]. HTA-Newsletter 22: p. 2.

Wild, C. (2003): [Endoscopic sinus surgery for nasal polyps]. HTA-Newsletter 22: pp. 3-4.

Wild, C. (2003): [High-dose chemotherapy]. HTA-Newsletter 22: p. 4.

Wild, C. (2003): [Extracorporeal shock wave therapy (ESWT) for pseudarthrosis]. HTA-Newsletter 22: pp. 2-3.

Wild, C. (2003): [High-dose lymphoablative therapy (HDLT) for severe autoimmune diseases]. HTA-Newsletter 21: pp. 2-3.

Wild, C. (2003): [Graftskin (Apligraf®) in the treatment of venous leg ulcers]. HTA-Newsletter 21: pp. 3-4.

Wild, C. (2003): [Recombinant human growth hormone (GH) therapy]. HTA-Newsletter 21: p. 2.

Wild, C. (2003): [Tools for decision-making. Editorial]. HTA-Newsletter 21: p. 1.

Wild, C. (2003): [Computed tomography in screening for lung cancer]. HTA-Newsletter 21: p. 4.

Wild, C. (2003): [Decision making: A systematic checklist]. ITA-Newsletter September 2003: p. 11.

Wild, C. (2003): [Ambulatory versus stationary haemodialysis for people with end-stage renal failure]. HTA-Newsletter 20: p. 4.

Wild, C. (2003): [HTA in hospitals]. ITA-Newsletter September 2003: pp. 9-10.

Wild, C. (2003): [The digestive endoscopic imaging capsule]. HTA-Newsletter 20: pp. 2-3.

Wild, C. (2003): [MARS® liver support]. HTA-Newsletter 20: p. 2.

Wild, C. (2003): [Autologous chondrocyte transplantation of the knee]. HTA-Newsletter 20: pp. 3-4.

Wild, C. (2003): [Clinical economics]. ITA-Newsletter September 2003: pp. 10-11.

Wild, C. (2003): [HTA and the commercialisation of new technologies. Editorial]. HTA-Newsletter 20: p. 1.

Wild, C. (2003): [Clinical economics. Editorial]. HTA-Newsletter 19: pp. 1-2.

Wild, C. (2003): [Viscosupplementation in the treatment of osteoarthritis]. HTA-Newsletter 19: pp. 3-4.

Wild, C. (2003): [Extracorporeal immunoadsorption treatment]. HTA-Newsletter 19: pp. 2-3.

Wild, C. (2003): [Tumour vaccination]. HTA-Newsletter 19: p. 4.

Wild, C. (2003): [Liquid-based cytology in cervical screening]. HTA-Newsletter 19: p. 2.

Wild, C. and Jonas, S. (2003): [To what extent can the publicly sponsored health system afford predictive genetic diagnostics? - First approaches to pinpoint and limit responsibilities, exemplified by hereditary carcinomas]. Das Gesundheitswesen 65 (06): pp. 351-358.

Wild, C. (2003): [Treatment of chronic pain: Multidisciplinary programmes]. HTA-Newsletter 18: pp. 3-4.

Wild, C. (2003): [Virtual colonoscopy]. HTA-Newsletter 18: pp. 2-3.

Wild, C. (2003): [Troponin testing in acute coronary syndromes]. HTA-Newsletter 18: p. 4.

Wild, C. (2003): [Patient information in screening programmes. Editorial]. HTA-Newsletter 18: pp. 1-2.

Wild, C. (2003): [Activated protein C for severe sepsis]. HTA-Newsletter 18: p. 2.

Wild, C. (2003): [Pegylated interferon alpha for chronic hepatitis C]. HTA-Newsletter 17: pp. 3-4.

Wild, C. (2003): [Vertebroplasty and kyphoplasty]. HTA-Newsletter 17: pp. 2-3.

Wild, C. (2003): [Decision making in health care. Editorial]. HTA-Newsletter 17: p. 1.

Wild, C. (2003): [Anaesthetics in day surgery]. HTA-Newsletter 17: p. 4.

Wild, C. (2003): [Racz-catheter for chronic back pain]. HTA-Newsletter 17: p. 2.

Wild, C. (2003): [Mental illness and the identification of risk groups]. HTA-Newsletter 16: p. 2.

Wild, C. (2003): [Interventions for preventing obesity in children and adolescents]. HTA-Newsletter 16: pp. 2-3.

Wild, C. (2003): [Health promotion in companies and schools]. HTA-Newsletter 16: p. 4.

Wild, C. (2003): [Lifestyle and physical activity]. HTA-Newsletter 16: pp. 3-4.

Trummer, U. (2003): [Evidence-based health promotion. Editorial]. HTA-Newsletter 16: pp. 1-2.

Wild, C. (2003): [Endovascular surgery for abdominal aortic aneurysm/AAA]. HTA-Newsletter 15: p. 4.

Wild, C. (2003): [Evaluating organisational performance: Quantitative and qualitative methods]. ITA-Newsletter March 2003: p. 9.

Wild, C. and Groth, S. (2003): . ITA-Newsletter March 2003: p. 8.

Wild, C. (2003): [Foundation of the Austrian network "HTA in hospitals". Editorial]. HTA-Newsletter 15: p. 1.

Wild, C. (2003): [Digital mammography/DM]. HTA-Newsletter 15: pp. 2-3.

Wild, C. (2003): [Medical one-way devices]. HTA-Newsletter 15: p. 3.

Wild, C. (2003): [Diagnosis of osteoporosis]. HTA-Newsletter 15: p. 2.

Wild, C. (2003): [Implantable cardioverter defibrillator]. HTA-Newsletter 14: p. 4.

Wild, C. (2003): [Newborn hearing screening]. HTA-Newsletter 14: pp. 2-3.

Wild, C. (2003): [Use of genotypic resistance testing to optimise HIV-therapy]. HTA-Newsletter 14: p. 3.

Wild, C. (2003): [Electromagnetic field therapy]. HTA-Newsletter 14: p. 2.

Wild, C. (2003): [Organisational performance and its appraisal. Editorial]. HTA-Newsletter 14: p. 1.

Wild, C. (2003): [Erythropoietin: The impact of HTA]. ÖKZ: Österreichische Krankenhauszeitung 44 (12): pp. 9-10.

Wild, C. (2003): [Erythropoietin: The impact of HTA] . Mitteilungen der Sanitätsverwaltung 104 (9): p. 23.

Wild, C. and Narath, M. (2003): [Evidence-based intensive care planning. A systematic review of recent ICU-plans and planning approaches]. Intensivmedizin und Notfallmedizin 40 (05): pp. 412-419.

Wild, C. and Frank, W. and Huber, K. and Konta, B. (2003): [GP IIb/IIIA inhibitors in the treatment of patients with coronary heart disease]. Köln: DIMDI. ISBN 3-89906-703-7.

Jonas, S. and Wild, C. and Schamberger, C. (2003): [Predictive genetic testing for breast and colorectal cancer]. ZaeFQ: Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 97 (01): pp. 67-71.